Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)

Autor: Pastick KA, Okafor EC, Wang F, Lofgren SM, Skipper CP, Nicol MR, Pullen MF, Rajasingham R, McDonald EG, Lee TC, Schwartz IS, Kelly LE, Lother SA, Mitjà O, Letang E, Abassi M, Boulware DR

Publikováno v: Open Forum Infectious Diseases
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Universidad de Alicante (UA)
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and chloroquine have garnered unprecedented attention as potential therapeutic agents a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::61316ba34d288ee2133526e25a00c147
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1171

Baseline C-reactive Protein as a Risk Factor for Cryptococcal Meningitis and Death in HIV-associated Cryptococcal Antigenemia With CrAg Titer as an Effect Modifier.

Autor: Skipper CP; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Kirumira P; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda., Dai B; Division of Biostatistics & Health Data Science, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Wele A; Division of Biostatistics & Health Data Science, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Naluyima R; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda., Namuli T; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda., Turya F; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda., Muhumuza P; Masaka Field Station, Medical Research Council/Uganda Virus Institute & London School of Hygiene and Tropical Medicine Uganda Research Unit, Masaka, Uganda., Kibengo F; Masaka Field Station, Medical Research Council/Uganda Virus Institute & London School of Hygiene and Tropical Medicine Uganda Research Unit, Masaka, Uganda., Boulware DR; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Meya DB; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Nalintya E; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda., Rajasingham R; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jul 08; Vol. 11 (8), pp. ofae392. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).

Impact of Cerebrospinal Fluid Leukocyte Infiltration and Neuroimmmune Mediators on Survival with HIV-Associated Cryptococcal Meningitis.

Autor: Okurut S; Research Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda.; Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda., Boulware DR; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Manabe YC; Research Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda.; Division of Infectious Diseases, Department of Medicine, John Hopkins University School of Medicine, Baltimore, Maryland, MD, USA., Tugume L; Research Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda., Skipper CP; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Ssebambulidde K; Research Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda., Rhein J; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Musubire AK; Research Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda., Akampurira A; Research Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda.; Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda., Okafor E; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Olobo JO; Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda., Janoff EN; Mucosal and Vaccine Research Program Colorado, Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado, CO. USA.; Rocky Mountain Regional Veterans Affairs Medical Center, Aurora CO, USA., Meya DB; Research Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda.; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.; Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 May 31. Date of Electronic Publication: 2024 May 31.

Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.

Autor: Boulware DR; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Atukunda M; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Kagimu E; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Musubire AK; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Akampurira A; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Tugume L; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Ssebambulidde K; Infectious Diseases Institute, Makerere University, Kampala, Uganda.; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Kasibante J; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Nsangi L; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Mugabi T; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Gakuru J; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Kimuda S; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Kasozi D; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Namombwe S; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Turyasingura I; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Rutakingirwa MK; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Mpoza E; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Kigozi E; Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda., Muzoora C; Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda., Ellis J; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Skipper CP; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Matkovits T; Matinas Biopharma Nanotechnologies, Bedminster, New Jersey, USA., Williamson PR; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Williams DA; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Fieberg A; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Hullsiek KH; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Abassi M; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Dai B; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Meya DB; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; Infectious Diseases Institute, Makerere University, Kampala, Uganda.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Dec 15; Vol. 77 (12), pp. 1659-1667.

Effect of Coronavirus Disease 2019 Lockdowns on Identification of Advanced Human Immunodeficiency Virus Disease in Outpatient Clinics in Uganda.

Autor: Nalintya E; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Sekar P; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA., Kavuma P; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Kigozi J; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Ssuna M; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Kirumira P; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Naluyima R; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Namuli T; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Musa FT; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Skipper CP; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA., Hullsiek KH; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA., Ellis J; Infectious Diseases Institute, Makerere University, Kampala, Uganda.; Clinical Research Department, London School of Hygiene and Tropical Medicine, United Kingdom., Boulware DR; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA., Meya DB; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Rajasingham R; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jun 08; Vol. 76 (11), pp. 2014-2017.